PMID- 17274962 OWN - NLM STAT- MEDLINE DCOM- 20070521 LR - 20141120 IS - 0006-8993 (Print) IS - 0006-8993 (Linking) VI - 1138 DP - 2007 Mar 23 TI - Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. PG - 221-30 AB - The formation of Abeta and its subsequent deposition in senile plaques are considered to be initial events that lead to a cascade of pathological changes in AD. Mediators of Abeta-induced oxidative stress are known to cause oxidative damage to macromolecules. However, the molecular mechanisms by which Abeta-induced oxidative stress leads to neuronal cell death are not fully understood. Here we show that Abeta-induced oxidative stress activates the pro-death gene BNIP3. Abeta treatment results in mitochondrial dysfunction, accumulation of reactive oxygen species, and subsequent expression of BNIP3 in rat primary cortical neurons. Pretreatment with antioxidants abolished Abeta-induced BNIP3 expression and attenuated cell death, demonstrating the role of oxidative stress in BNIP3 induction. Abeta-induced BNIP3 expression may be mediated by hypoxia-inducible factor-1 (HIF-1) because Abeta-treatment induced accumulation and nuclear translocation of HIF-1 and knock-down of HIF-1 by RNAi inhibited BNIP3 expression. Finally, knockdown of BNIP3 reduced Abeta-induced neuronal death. Together, these results suggest a potential pathological role of BNIP3 in the etiology of AD. FAU - Zhang, Surong AU - Zhang S AD - Department of Human Anatomy and Cell Science, University of Manitoba Faculty of Medicine, 730 William Avenue, Winnipeg, Manitoba, Canada R3E 0W3. FAU - Zhang, Zhengfeng AU - Zhang Z FAU - Sandhu, Garry AU - Sandhu G FAU - Ma, Xiuli AU - Ma X FAU - Yang, Xuefen AU - Yang X FAU - Geiger, Jonathan D AU - Geiger JD FAU - Kong, Jiming AU - Kong J LA - eng GR - P20RR017699/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20070108 PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (Amyloid beta-Peptides) RN - 0 (BNIP3 protein, rat) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Membrane Proteins) RN - 0 (Mitochondrial Proteins) RN - 0 (Neurotoxins) RN - 0 (Peptide Fragments) RN - 0 (Proto-Oncogene Proteins) RN - 0 (amyloid beta-protein (25-35)) SB - IM MH - Amyloid beta-Peptides/*pharmacology MH - Animals MH - Cell Death MH - Cells, Cultured MH - Cerebral Cortex/drug effects/*metabolism MH - Embryo, Mammalian MH - Female MH - Hypoxia-Inducible Factor 1/metabolism MH - Membrane Proteins/antagonists & inhibitors/genetics/*metabolism MH - Mitochondria/metabolism MH - Mitochondrial Proteins MH - Neurons/drug effects MH - Neurotoxicity Syndromes/*metabolism/physiopathology MH - Neurotoxins/*pharmacology MH - *Oxidative Stress MH - Peptide Fragments/*pharmacology MH - Proto-Oncogene Proteins/antagonists & inhibitors/genetics/*metabolism MH - RNA Interference MH - Rats MH - Rats, Sprague-Dawley EDAT- 2007/02/06 09:00 MHDA- 2007/05/22 09:00 CRDT- 2007/02/06 09:00 PHST- 2006/06/23 00:00 [received] PHST- 2006/12/25 00:00 [revised] PHST- 2006/12/27 00:00 [accepted] PHST- 2007/02/06 09:00 [pubmed] PHST- 2007/05/22 09:00 [medline] PHST- 2007/02/06 09:00 [entrez] AID - S0006-8993(06)03736-X [pii] AID - 10.1016/j.brainres.2006.12.086 [doi] PST - ppublish SO - Brain Res. 2007 Mar 23;1138:221-30. doi: 10.1016/j.brainres.2006.12.086. Epub 2007 Jan 8.